VASSAR BROTHERS MEDICAL CENTER — History
CCN 330023 | 3-year financial timeline | COVID resilience: 65/100
🛡️ Public data only — no PHI permitted on this instance.
$735M
Latest Revenue (FY2022)
+8.5%
Revenue CAGR (3yr)
-2.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $625M | $694M | $735M | +5.9% | +8.5% |
| Operating Expenses | $673M | $729M | $754M | +3.5% | +5.8% |
| Operating Margin | -7.7% | -5.0% | -2.6% | +48.5% | +0.0% |
| Net Income | $-48M | $-35M | $-19M | +45.4% | +0.0% |
| Licensed Beds | 365 | 341 | 340 | -0.3% | -3.5% |
| Total Patient Days | 94,576 | 98,830 | 97,838 | -1.0% | +1.7% |
| Medicare Day % | 41% | 41% | 38% | -6.0% | -3.1% |
| Medicaid Day % | 5% | 5% | 5% | +8.2% | -1.3% |
COVID Impact & Recovery
Resilience Score: 65/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +17.7% ($625M → $735M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+8.5%
This Hospital
+7.6%
State Avg
Latest Margin
-2.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $790M | 0.0% |
| FY2024 (proj) | $846M | 2.6% |
| FY2025 (proj) | $901M | 5.2% |